Cytokines in hematopoiesis

International Reviews of Immunology

Volumn 16, Issue 5-6, 1998, Pages 651-682

  Alexander, Warren S ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Colony stimulating factor; Cytokine; Erythropoietin; Hematopoiesis; Thrombopoietin

Indexed keywords

BLOOD CELL; BONE MARROW CELL; CELL INTERACTION; CELL SURFACE; CLONING; COLONY STIMULATING FACTOR; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE; HEMATOPOIESIS; MACROPHAGE; MOUSE; PRECURSOR CELL; STEM CELL;

EID: 0031803784     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809043013     Document Type: Article

References (116)

1. Mayani, H., Guilbert, L.J., Janowska-Wieczorek, A. Biology of the hemopoietic microenvironment. Eur. J. Haematol., 49, 225-233, 1992.
2. Nicola, N.A. Guidebook to cytokines and their receptors. Oxford University Press, Oxford, 1994.
3. Metcalf, D. Hematopoietic regulators: redundancy or subtlety? Blood, 82, 3515-3523, 1993.
4. + cells purified from cord blood and fetal liver. Exp. Hematol., 23, 422-427, 1995.
5. Heldin, C.-H. Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223, 1995.
6. Metcalf, D. The Florey Lecture, 1991. The colony-stimulating factors: discovery to clinical use. Phil. Trans. R. Soc. Lond., 333, 147-173, 1991.
7. Oheda, M., Hasegawa, M., Hattori, K., Kuboniwa, H., Kojima, T., Orita, T., Tomonou, K., Yamazaki, T., Ochi, N. O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J. Biol. Chem., 265, 11432-11435, 1990.
8. Cebon, J., Nicola, N.A., Ward, M., Gardner, I., Dempsey, P., Layton, J., Duehrsen, U., Burgess, A.W., Nice, E., Morstyn, G. Granulocyte-macrophage colony-stimulating factor from human lymphocytes. J. Biol. Chem., 265, 4483-4491, 1990.
9. Metcalf, D., Nicola, N.A., Gough, N.M. Hormones and blood cell production. In: Endocrinology 3rd ed. Ed. Degroot, L.J., Saunders, Philadelphia, 1995.
10. Sallerfors, B. Endogenous production and peripheral blood levels of granulo cyte-macrophage (GM-) and granulocyte (G-) colony-stimulating factors. Leukemia and Lymphoma, 13, 235-247, 1994.
11. Metcalf, D., Willson, T.A., Hilton, D.J., DiRago, L., Mifsud, S. Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: measurement by specific bioassays. Leukemia, 9, 1556-1564, 1995.
12. Bartocci, A., Pollard, J.W., Stanley, E.R. Regulation of colony-stimulating factor-1 during pregnancy. J. Exp. Med., 164, 956-961, 1986.
13. Nimer, S.D., Uchida, H. Regulation of granulocyte-macrophage colony-stimulating factor and interleukin-3 expression. Stem Cells, 13, 324-335, 1995.
14. 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J. Cell. Physiol., 124, 313-321, 1985.
15. Fukunaga, R., Ishizaka-Ikeda, E., Nagata, S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J. Biol. Chem., 265, 14008-14015, 1990.
16. Nicola, N.A., Metcalf, D. Subunit promiscuity among hemopoietic growth factor receptors. Cell, 67, 1-4, 1991.
17. Roberts, W.M., Shapiro, L.H., Ashmun, R.A., Look, A.T. Transcription of the human colony-stimulating factor-1 receptor gene is regulated by separate tissue-specific promoters. Blood, 79, 586-593, 1992.
18. Demetri, G.D., Griffin, J.D. Granulocyte colony-stimulating factor and its receptor. Blood, 78, 2791-2808, 1991.
19. Gasson, J.C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood, 77, 1131-1145, 1991.
20. Metcalf, D. Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. Proc. Natl. Acad. Sci. USA, 77, 5327-5330, 1980.
21. Metcalf, D., Burgess, A.W., Johnson, G.R., Nicola, N.A., Nice, E.C., DeLamarter, J., Thatcher, D.R., Mermod, J.-J. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. J. Cell. Physiol., 128, 421-431, 1986.
22. Williams, G.T., Smith, C.A., Spooncer, E., Dexter, T.M., Taylor, D.R. Hematopoietic colony-stimulating factors promote cell survival by suppressing apoptosis. Nature, 343, 76-79, 1990.
23. Metcalf, D., Burgess, A.W. Clonal analysis of progenitor cell commitment to granulocyte or macrophage production. J. Cell. Physiol., 111, 275-283, 1982.
24. Metcalf, D. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. Proc. Natl. Acad. Sci. USA, 88, 11310-11314, 1991.
25. Hill, A.D.K., Naama, H.A., Calvano, S.E., Daly, J.M. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J. Leuk. Biol., 58, 634-642, 1995.
26. Steinman, R.M. Dendritic cells and immune-based therapies. Exp. Hematol., 24, 859-862, 1996.
27. Pojda, Z., Molineux, G., Dexter, T.M. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp. Hematol., 18, 27-31, 1990.
28. Welte, K., Bonilla, M.A., Gillio, A.P., Boone, T.C., Potter, G.K., Gabrilove, J.L., Moore, M.A.S., O'Reilly, R.J., Souza, L.M. Recombinant human granulocyte colony-stimulating factor. J. Exp. Med., 165, 941-948, 1987.
29. Lindemann, A., Herrmann, F., Oster, W., Haffner, G., Meyenburg, W., Souza, L.M., Mertelsmann, R. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood, 74, 2644-2651, 1989.
30. Duehrsen, U., Villeval, J.-L., Boyd, J., Kannourakis, G., Morstyn, G., Metcalf, D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood, 72, 2074-2081, 1988.
31. Scheuning, F.G., Storb, R., Goehle, S., Graham, T.C., Appelbaum, F.R., Hackman, R., Souza, L.M. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood, 74, 1308-1313, 1989.
32. Chang, J.M., Metcalf, D., Gonda, T.J., Johnson, G.R. Long-term exposure to retrovirally expressed granulocyte colony-stimulating factor induces a non-neoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J. Clin. Invest., 84, 1488-1496, 1989.
33. Metcalf, D., Begley, C.G., Williamson, D.J., Nice, E.C., DeLamarter, J., Mermod, J.-J., Thatcher, D., Schmidt, A. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol., 15, 1-9, 1987.
34. Lieschke, G.J., Maher, D., Cebon, J., O'Connor, M., Green, M., Sheridan, W., Boyd, A., Rallings, M., Bonnem, E., Metcalf, D., Burgess, A.W., McGrath, K., Fox, R.M., Morstyn, G. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Ann. Internal Med., 110, 357-364, 1989.
35. Socinski, M.A., Elias, A., Schnipper, L., Cannistra, S.A., Antman, K.H., Griffin, J.D. Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet, 1, 1194-1198, 1988.
36. Nienhuis, A.W., Donahue, R.E., Karlsson, S., Clark, S.C., Agricola, B , Antinoff, N., Pierce, J.E., Turner, P., Anderson, W.F., Nathan, D.G. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous transplantation in a primate model. J. Clin. Invest., 80, 573-577, 1987.
37. Lang, R.A., Metcalf, D., Cuthbertson, R.A., Lyons, I., Stanley, E., Kelso, A., Kannourakis, G., Williamson, D.J., Klintworth, G.K., Gonda, T.J., Dunn, A.R. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell, 51, 675-686, 1987.
38. Johnson, G.R., Gonda, T.J., Metcalf, D., Hariharan, I.K., Cory, S. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony-stimulating factor. EMBO J., 8, 441-448, 1989.
39. Metcalf, D., Begley, C.G., Johnson, G.R., Nicola, N.A., Lopez, A.F., Williamson, D.J. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood, 68, 46-57, 1986.
40. Wagemaker, G., van Gils, F.C.J.M., Burger, H., Dorssers, L.C.J., van Leen, R.W., Persoon, N.L.M., Wielenga, J.J., Heeney, J.L., Knol, E. Highly increased production of bone marrow-derived blood cells by administration of homologous interleukin-3 to rhesus monkeys. Blood, 76, 2235-2241, 1990.
41. Ottman, O.G., Ganser, A., Seipelt, G., Eder, M., Schulz, G., Hoelzer, D. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood, 76, 1494-1502, 1990.
42. Geissler, K., Valent, P., Mayer, P., Liehl, E., Hinterberger, W., Lechner, K., Bettleheim, P. Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates - synergism with recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 75, 2305-2310, 1990.
43. Gillio, A.P., Gasparetto, C., Laver, J., Abboud, M., Bonilla, M.A., Garnick, M.B., O'Reilly, R.J. Effects of interleukin-3 on hematopoietic recovery after 5-fluoro-uracil or cyclophosphamide treatment of cynomolgus primates. J. Clin. Invest., 85, 1560-1565, 1990.
44. Chang, J.M., Metcalf, D., Lang, R.A., Gonda, T.J., Johnson, G.R. Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. Blood, 73, 1487-1497, 1989.
45. Hume, D.A., Pavli, P., Donahue, R.E., Fidler, I.J. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol., 141, 3405-3409, 1988.
46. Munn, D.H., Garnick, M.B., Cheung, N.-K.V. Effects of parenteral recombinant macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood, 75, 2042-2048, 1990.
47. Vose, J.M., Armitage, J.O. Clinical applications of hematopoietic growth factors. J. Clin. Oncol., 13, 1023-1035, 1995.
48. Weite, K., Gabrilove, J., Bronchud, M.H., Platzer, E., Morstyn, G. Filgrastim (r-metHuG-CSF): the first 10 years. Blood, 88, 1907-1929, 1996.
49. Gianella-Borridori, A. Present and future clinical relevance of interleukin-3. Stem Celts, 12(suppl 1), 241-248, 1994.
50. Hammond, W.P., Price, T.H., Souza, L.M., Dale, D.C. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. New Engl. J. Med., 320, 1306-1311, 1989.
51. Dale, D.C. Hematopoietic growth factors for the treatment of severe chronic neutropenia. Stem Cells, 13, 94-100, 1995.
52. Cairo, M.S., Plunkett, J.M., Mauss, D., van den Ven, C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and Group B Streptococcus sepsis. Blood, 76, 1788-1794, 1990.
53. Miles, S.A., Mitsuyasu, R.T., Moreno, J., Baldwin, G., Alton, N.K., Souza, L., Glaspy, J.A. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood, 77, 2109-2117, 1991.
54. Koerbling, M., Champlin, R. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells, 14, 185-195, 1996.
55. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., Mulligan, R.C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90, 3539-3543, 1993.
56. Morita, T., Ikeda, K., Douzono, M., Yamada, M., Kimura, F., Kawakami, K., Sasaki, K., Motoyoshi, K., Takahara, J., Irino, S. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood, 88, 955-961, 1996.
57. Koller, B.H., Smithies, O. Altering genes in animals by gene targeting. Ann. Rev. Immunol., 10, 705-730, 1992.
58. Hammond, W.P., Csiba, E., Canin, A., Hockman, H., Souza, L.M., Layton, J.E., Dale, D.C. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J. Clin. Invest., 87, 704-710, 1991.
59. Lieschke, G.J., Grail, D., Hodgson, G., Metcalf, D., Stanley, E., Cheers, C., Fowler, K.J., Basu, S., Zhan, Y.F., Dunn, A.R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood, 84, 1737-1746, 1994.
60. Stanley, E., Lieschke, G.J., Grail, D., Metcalf, D., Hodgson, G., Gall, J.A.M., Maher, D.W., Cebon, J., Sinickas, V., Dunn, A.R. Granulocyte-macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA, 91, 5592-5596, 1994.
61. Dranoff, G., Crawford, A.D., Sadelain, M., Ream, B., Rashid, A., Bronson, R.T., Dickersin, G.R., Bachurski, C.J., Mark, E.L., Whittsett, J.A., Mulligan, R.C. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science, 264, 713-716, 1994.
62. Robb, L., Drinkwater, C.C., Metcalf, D., Li, R., Koentgen, F., Nicola, N.A., Begley, C.G. Hematopoietic and lung abnormalities in mice with a null mutation of the common β subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA, 92, 9565-9569, 1995.
63. c receptor exhibit lung pathology and impaired immune response, while βIL-3 receptor-deficient mice are normal. Immunity, 2, 211-222, 1995.
64. c receptor-deficient mice is reversed by bone marrow transplantation. J. Exp. Med., 183, 2657-2662, 1996.
65. Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L.D., Nishikawa, S.-I. The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature, 345, 442-444, 1990.
66. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A.W., Ahmed-Ansari, A., Sell, K.W., Pollard, J.W., Stanley, E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA, 87, 4828-4832, 1990.
67. Liggett, W., Shevde, N., Anklesaria, P., Sohoni, S., Greenberger, J., Glowacki, J. Effects of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells. Stem Cells, 11, 398-411, 1993.
68. Fuller, K., Owens, J.M., Jagger, C.J., Wilson, A., Moss, R., Chambers, T.J. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med., 178, 1733-1744, 1993.
69. Wiktor-Jedrzejczak, W., Ratajczak, M.Z., Ptasznik, A., Sell, K.W., Ahmed-Ansari, A., Ostertag, W. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp. Hematol., 20, 1004-1010, 1992.
70. Nilsson, S.K., Lieschke, G.J., Garcia-Wijnen, C.C., Williams, B., Tzelepis, D., Hodgson, G., Grail, D., Dunn, A.R., Bertoncello, I. Gramilocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood, 86, 66-72, 1995.
71. Lieschke, G.J., Stanley, E., Grail, D., Hodgson, G., Sinickas, V., Gall, J.A.M., Sinclair, R.A., Dunn, A.R. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and co-existent osteopetrosis and severe lung disease. Blood, 84, 27-35, 1994.
72. Morris, C.F., Salisbury, J., Kobayashi, M., Townsend, P.V., Hapel, A.J. Interleukin-3 alone does not support the proliferation of bone marrow cells from A/J mice: a novel system for studying the synergistic activities of IL-3. Br. J. Haematol., 74, 131-137, 1990.
73. Ichihara, M., Hara, T., Takagi, M., Cho, L.C., Gorman, D.M., Miyajima, A. Impaired interleukin-3 (IL-3) response of the A/J mouse is caused by a branch point deletion in the IL-3 receptor a subunit gene. EMBO J., 14, 939-950, 1995.
74. Miyake, T., Kung, C.K., Goldwasser, E. Purification of human erythropoietin. J. Biol. Chem., 252, 5558-5564, 1977.
75. Krantz, S.B. Erythropoietin. Blood, 77, 419-434, 1991.
76. Bauer, C. Erythropoietin - from gene structure to therapeutic applications. J. Perinat. Med., 23, 77-81, 1995.
77. Watowich, S.S., Hilton, D.J., Lodish, H.F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol., 14, 3535-3549, 1994.
78. Philo, J.S., Aoki, K.H., Arakawa, T., Narhi, L.O., Wen, J. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry, 35, 1681-1691, 1996.
79. Wong, P.M.C., Chung, S.-W., Reicheid, S.M., Chui, D.H.K. Hemoglobin switching during murine embryonic development: evidence for two populations of embryonic erythropoietic progenitor cells. Blood, 67, 716-721, 1986.
80. Keller, G., Kennedy, M., Papayannopoulou, T., Wiles, M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol., 13, 473-486, 1993.
81. Gordon, M.S., Hoffman, R. Growth factors affecting human thrombocytopoiesis; potential agents for the treatment of thrombocytopenia. Blood, 80, 302-307, 1992.
82. Spivak, J.L. The mechanism of action of erythropoietin. Int. J. Cell Cloning, 4, 139-166, 1986.
83. Hara, H., Ogawa, M. Erythropoietic precursors in mice under erythropoietic stimulation and suppression. Exp. Hematol., 5, 141-148, 1977.
84. Dessypris, E.N., Graber, S.E., Krantz, S B., Stone, W.J. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood, 72, 2060-2062, 1988.
85. Wu, H., Liu, X., Jaenisch, R., Lodish, H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell, 83, 59-67, 1995.
86. Lin, C.-S., Lim, S.-K., D'Agati, V., Constantini, F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Devel., 10, 154-164, 1996.
87. Semenza, G.L., Traystman, M.D., Gearhart, J.D., Antonarakis, S.E. Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, 86, 2301-2305, 1989.
88. Villeval, J.-L., Metcalf, D., Johnson, G.R. Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells. Leukemia, 6, 107-115, 1992.
89. Souyri, M., Vigon, I., Penciolelli, J.-F., Heard, J.-M., Tambourin, P., Wendling, F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell, 63, 1137-1147, 1990.
90. Alexander, W.S., Metcalf, D., Dunn, A.R. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J., 14, 5569-5578, 1995.
91. Methia, N., Louache, F., Vainchenker, W., Wendling, F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood, 82, 1395-1401, 1993.
92. Kaushansky, K. Thrombopoietin: the primary regulator of platelet production. Blood, 86, 419-431, 1995.
93. Hunt, P. The physiologic role and therapeutic potential of the Mp-ligand in thrombopoiesis. Stem Cells, 13, 579-587, 1995.
94. Fielder, P.J., Gurney, A.L., Stefanich, E., Marian, M., Moore, M.W., Carver-Moore, K., deSauvage, F.J. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood, 87, 2154-2161, 1996.
95. Nagahisa, H., Nagata, Y., Ohnuki, T., Osada, M., Nagasawa, T., Abe, T., Todokoro, K. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood, 87, 1309-1316, 1996.
96. McCarty, J.M., Sprugel, K.H., Fox, N.E., Sabath, D.E., Kaushanski, K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood, 86, 3668-3675, 1995.
97. Stoffel, R., Wiestner, A., Skoda, R.C. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood, 87, 567-573, 1996.
98. Wallace, P.M., MacMaster, J.F., Rillema, J.R., Peng, J., Burstein, S.A., Shoyab, M. Thrombocytopoietic properties of oncostatin M. Blood, 86, 1310-1315, 1995.
99. Choi, E.S., Hokom, M., Bartley, T., Li, Y.-S., Ohashi, H., Kato, T., Nichol, J.L., Skrine, J., Knudten, A., Chen, J., Hornkohl, A., Grampp, G., Sleeman, L., Cole, S., Trail, G., Hunt, P. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells, 13, 317-322, 1995.
100. Oda, A., Miyakawa, Y., Druker, B.J., Ozaki, K., Yabusaki, K., Shirasawa, Y., Handa, M., Kato, T., Miyazaki, H., Shimosaka, A., Ikeda, Y. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood, 87, 4664-4670, 1996.
101. Montruccio, G., Brizzi, M.F., Calosso, G., Marengo, S., Pegoraro, L., Camussi, G. Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood, 87, 2762-2768, 1996.
102. Farese, A.M., Hunt, P., Boone, T., MacVittie, T.J. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal non-human primates. Blood, 86, 54-59, 1995.
103. Harker, L. A., Hunt, P., Marzec, U.M., Kelly, A.B., Tomer, A., Hanson, S.R., Stead, R.B. Regulation of platelet production and function by megakaryocyte growth and development factor in non-human primates. Blood, 87, 1833-1844, 1996.
104. Basser, R.L., Rasko, J.E.J., Clarke, K., Cebon, J., Green, M.D., Hussein, S., Menchaca, D., Tomita, D., Marty, J., Fox, R.M., Begley, C.G. Preliminary report: thrombopoietic effects of pegylated recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet, 348, 1279-1281, 1996.
105. Harker, L.A., Marzec, U.M., Hunt, P., Kelly, A.B., Tomer, A., Cheung, E., Hanson, S.R., Stead, R.B. Dose-response of pegylated human megakaryocyte growth and development factor on platelet production and function in non-human primates. Blood, 88, 511-521, 1996.
106. O'Malley, C.J., Rasko, J.E.J., Basser, R.L., McGrath, K.M., Cebon, J., Grigg, A.P., Hopkins, W., Cohen, B., O'Byrne, J., Green, M.D., Fox, R.M., Bernt, M.C., Begley, C.G. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood, 88, 3288-3298, 1996.
107. Yan, X.-Q., Lacey, D., Hill, D., Chen, Y., Fletcher, F., Hawley, R.G., McNiece, I.K. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood, 88, 402-409, 1996.
108. Gurney, A.L., Carver-Moore, K., deSauvage, F.J., Moore, M.W. Thrombocytopenia in c-mpl-deficient mice. Science, 265, 1445-1447, 1994.
109. Alexander, W.S., Roberts, A.W., Nicola, N A., Li, R., Metcalf, D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood, 87, 2162-2170, 1996.
110. deSauvage, F.J., Carver-Moore, K., Luoh, S.-M., Ryan, A., Dowd, M., Eaton, D.L., Moore, M.W. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med., 183, 651-656, 1996.
111. Carver-Moore, K., Broxmeyer, H.E., Luoh, S.-M., Cooper, S., Peng, J., Burstein, S.A., Moore, M.W., deSauvage, F.J. Low levels of erythroid and myeloid progenitors in thrombopoietin and c-mpl-deficient mice. Blood, 88, 803-808, 1996.
112. KLu, H., Yonemura, Y., Kaushanski, K., Ogawa, M. Thrombopoietin, the Iigand for the Mpl receptor, synergizes with Steel factor and other early-acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood, 87, 4544-4551, 1996.
113. Sitnicka, E., Lin, N., Priestley, G.V., Fox, N., Broudy, V.C., Wolf, N.S., Kaushansky, K. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood, 87, 4998-5005, 1996.
114. Nichol, J.L., Hokom, M.M., Hornkohl, A., Sheridan, W.P., Ohashi, H., Kato, T., Li, Y.S., Bartley, T.D., Choi, E., Bogenberger, J., Skrine, J.D., Knudten, A., Chen, J., Trail, G., Sleeman, L., Cole, S., Grampp, G., Hunt, P. Megakaryocyte growth and development factor. J. Clin. Invest., 95, 2973-2978, 1995.
115. Hokom, M.M., Lacey, D., Kinstler, O.B., Choi, E., Kaufman, S., Faust, J., Rowan, C., Dwyer, E., Nichol, J.L., Grasel, T., Wilson, J., Steinbrink, R., Hecht, R., Winters, EX, Boone, T., Hunt, P. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood, 86, 4486-4492, 1995.
116. Farese, A.M., Hunt, P., Grab, L.B., MacVittie, T.J. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in non-human primates after radiation induced marrow aplasia, J. Clin. Invest., 97, 2145-2151, 1996.